Investigating how B cells respond to different antigens
Core B: Antigen Receptor Sequencing, Cloning, Expression, and Analysis Core
This study is looking at how special immune cells called B cells work and change when they encounter things like infections or transplants, which could help improve treatments for people with immune system issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11075846 on NIH RePORTER |
What this research studies
This research focuses on understanding the behavior of B cells, which are crucial components of the immune system that produce antibodies. By analyzing the unique receptors on B cells, researchers aim to track how these cells expand and adapt in response to various antigens, including those from transplants and infections. The study employs advanced sequencing techniques to gather detailed information about B cell receptor diversity and functionality, which could lead to improved treatments for conditions involving immune responses. Patients may benefit from insights gained into how their immune systems react to different challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals undergoing organ transplants or those with autoimmune disorders who may benefit from enhanced understanding of their immune responses.
Not a fit: Patients with stable, non-immune related conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better strategies for managing immune responses in patients, particularly in transplant settings or autoimmune diseases.
How similar studies have performed: Previous research has shown promising results in understanding B cell responses through similar sequencing approaches, indicating a strong potential for success in this area.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: King, Rodney Glenn — University of Alabama at Birmingham
- Study coordinator: King, Rodney Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.